Republic of Moldova vs Vanuatu: Deaths from Parkinson's disease
Republic of Moldova
9.6 deaths
in 2021
Vanuatu
7.28 deaths
in 2021
Republic of Moldova rank
172nd
Vanuatu rank
173rd
Deaths from Parkinson's disease over time
- Republic of Moldova
- Vanuatu
How they compare
Republic of Moldova currently reports 9.6 deaths against 7.28 deaths in Vanuatu, a difference of 2.32 deaths.
That makes Republic of Moldova's figure about 1.3 times Vanuatu's.
The two have swapped places 7 times across 22 shared years of data; in 2000 it was Vanuatu ahead.
Republic of Moldova ranks 172nd and Vanuatu ranks 173rd of 194 countries.
Across the 3 decades both report, Republic of Moldova averaged higher in 2 and Vanuatu in 1.
Head to head by decade
| Decade | Republic of Moldova | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.95 deaths | 5.59 deaths | 1.36 deaths | Republic of Moldova |
| 2010s | 6.89 deaths | 7.14 deaths | 0.249 deaths | Vanuatu |
| 2020s | 8.25 deaths | 7.51 deaths | 0.74 deaths | Republic of Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from parkinson's disease, Republic of Moldova or Vanuatu?
- Republic of Moldova, at 9.6 deaths against 7.28 deaths in Vanuatu as of 2021.
- What is the difference in deaths from parkinson's disease between Republic of Moldova and Vanuatu?
- 2.32 deaths, with Republic of Moldova ahead.
- How many years of comparable data are there for Republic of Moldova and Vanuatu?
- 22 years are reported by both, from 2000 to 2021.
- How do Republic of Moldova and Vanuatu rank globally for deaths from parkinson's disease?
- Republic of Moldova ranks 172nd and Vanuatu ranks 173rd of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes.